YPrime’s eCOA—
Purpose-Built For Patient-Centric Trials
With the average cost to bring a new drug to market averaging between $1-2 billion1, as an industry, we must do better. YPrime’s proven eCOA platform is built to give you certainty in data capture.
A top pharma company recently came to YPrime needing a speedy eCOA rescue for a Phase 3 study with 216 sites and 900 patients, across 34 countries. With YPrime’s pre-validated eCOA platform, we were able to effectively reduce timelines, improve data quality, and maximize retention with a patient-centered experience.
Clinical trials are key to unlocking life-saving treatments. YPrime’s eCOA platform is your key to data-driven success in clinical trial tech. From oncology and endocrinology to infectious and rare diseases, we’ve implemented hundreds of validated and copyrighted COA measures. Easy enough for patients and powerful enough for researchers, YPrime’s eCOA has a proven history of de-risking clinical trials.
Check out the latest industry insights by downloading our eCOA fact sheet here.